- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Heart failure
- Meeting Date: November 2020
- Public Summary Document (PSD) November 2020 PBAC Meeting - (PDF 1401KB)
- Public Summary Document (PSD) November 2020 PBAC Meeting - (Word 281KB)
Dapagliflozin – November 2020
Dapagliflozin: Tablet 10 mg; Forxiga®
Last updated
19 March 2021